Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Active drug: pimavanserin 17mg (2 strength tablets)
(D08969)		1件: Pimavanserin1件: Pimavanserin tartrate (D08969) 💬 2件: HTR2A,
HTR2C 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
2PIMAVANSERIN
(D08969)		1件: Pimavanserin1件: Pimavanserin tartrate (D08969) 💬 2件: HTR2A,
HTR2C 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
3Pimavanserin (ACP-103)
(D08969)		1件: Pimavanserin1件: Pimavanserin tartrate (D08969) 💬 2件: HTR2A,
HTR2C 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
4Pimavanserin 34 mg
(D08969)		1件: Pimavanserin1件: Pimavanserin tartrate (D08969) 💬 2件: HTR2A,
HTR2C 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
5PIMAVANSERIN TARTRATE
(D08969)		1件: Pimavanserin1件: Pimavanserin tartrate (D08969) 💬 2件: HTR2A,
HTR2C 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
6Pimavanserin tartrate (ACP-103)
(D08969)		1件: Pimavanserin1件: Pimavanserin tartrate (D08969) 💬 2件: HTR2A,
HTR2C 💬 		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬